Viewing nowCombinationTelmtwin Tablet 80/5 mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Samsung Pharm. Co., Ltd.

MFDS item code 201607312 · Approved 2016.12.28 · Insurance code 642306910
Treatment of essential hypertension not controlled with monotherapy
For patients with essential hypertension, if blood pressure control is insufficient with monotherapy using telmisartan or amlodipine, additional treatment or other drug combinations may be necessary. These medications help lower blood pressure and play an important role in preventing cardiovascular diseases. Maintaining blood pressure control can reduce the risk of conditions such as stroke and myocardial infarction, so continuous treatment and management are essential. Effective management of hypertension through proper medication use improves health.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients who should use this medicine with caution’). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication may cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, so it should not be used by pregnant women or women who may become pregnant. Additionally, patients who are allergic to any component of this medication, have severe liver dysfunction, hypotension, or serious heart-related problems should avoid this medication. Patients with weakened liver or kidney function, especially those with significantly reduced kidney function, should use this medication with caution and under strict medical supervision. Elderly patients or those with specific heart conditions should also be cautious while using this medication and dosage adjustments may be required. Since this medication lowers blood pressure, symptoms such as dizziness or hypotension may occur at the beginning of treatment, and if these symptoms arise, the patient should lie down and rest immediately, and seek medical assistance if necessary. There is a risk of hyperkalemia (increased potassium levels in the blood) while taking this medication, so regular blood tests to check potassium levels are necessary. Also, this medication may interact with other drugs, so if the patient is currently taking other medications, it should be reported to their healthcare provider. Especially when taken with grapefruit juice, the effect may be excessively increased, so it is advisable to avoid it. Caution is needed while driving or operating hazardous machinery, as drowsiness or dizziness may occur. In case of overdose, severe hypotension or heart problems may occur, requiring immediate medical attention. Finally, this medication is not recommended for children, and breastfeeding women should avoid taking it.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that can block light. Additionally, it is advisable to store the medication at room temperature between 1 and 30 degrees Celsius. This storage method helps to safely maintain the medication's efficacy.
This is a white and light gray, double convex, oval-shaped tablet.
30 tablets (10 tablets/PTPX3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Samsung Pharm. Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.